Change of Name

Recorded: 2005-12-09 Received: 2005-12-09 Pages: 12

Assignor

DAIICHI SUNTORY PHARMA CO., LTD.

Executed: 2005-10-04

Assignee

DAIICHI ASUBIO PHARMA CO., LTD.

7-2, KOJIMACHI 5-CHOME, CHIYODA-KU, TOKYO, JPX, JAPAN

Covered Properties (13)

Pyrrolothiazine and Pyrrolothiazepine Compounds Having Serotonin-2 Receptor Antagonistic and Alpha-1-Blocking Action

Application: 10/421,929 →

Arylpiperidinopropanol and Arylpiperazinopropanol Derivatives and Pharmaceuticals Containing the Same

Application: 10/331,508 →

Arylpiperidinol and Arylpiperidine Derivatives and Pharmaceuticals Containing the Same

Application: 10/196,362 →

Arylpiperidinopropanol and Arylpiperazinopropanol Derivatives and Pharmaceuticals Containing the Same

Application: 10/118,045 →

Novel receptors

Application: 10/094,417 →

A Chymase Inhibitor for the Treatment of Eosinophilia

Application: 09/959,358 →

Preventive or Therapeutic Drugs for Fibrosis Containing Chymase Inhibitors as the Active Ingredient

Application: 09/959,232 →

Pyrrolothiazine and Pyrrolothiazepine Compounds Having Serotonin-2 Receptor Antagonistic and Alpha-1-Blocking Action

Application: 09/939,829 →

1-Aryl-1,8-Naphthylidin-4-One Derivative as Type Iv Phosphodiesterase Inhibitor

Application: 09/907,741 →

Blood Vessel Lipid Deposition-Preventive Agent Comprising Chymase-Inhibitor

Application: 09/869,360 →

Antibacterial Medicinal Compositions

Application: 09/856,094 →

Pyrrolothiazine and Pyrrolothiazepine Compounds Having Serotonin-2 Receptor Antagonistic and Alpha-1-Blocking Action

Application: 09/871,655 →

Quinazoline Derivatives and Pharmaceutical Applications Therof

Application: 09/763,213 →